Keyword: uniformity

  • The National Horsemen's Benevolent and Protective Association medication forum on Feb. 5

    Is Regulation Itself Thwarting Uniformity?

    Achieving true uniformity in equine medication and testing goes well beyond basic adoption of model rules, according to attorneys, horsemen, and veterinarians who picked apart the current system Feb. 5.

  • Commentary: Saving, Not Destroying the House

    Arthur Hancock III responds to accusations that supporters of a federal role in curbing medication use in racehorses are hurting the sport. These actions are necessary to save racing, he says.

  • WV to Tackle Latest Round of Model Rules

    Thoroughbred industry stakeholders in West Virginia will meet May 6 to consider changes in the state's racing rules, including a few related to the National Uniform Medication Program.

  • Drug Uniformity Remains Somewhat Elusive

    Though studies have been completed to determine threshold levels for almost 20 therapeutic medications, it doesn't mean the industry will know for certain whether the drugs can impact equine performance.

  • Horsemen on Drug Rules: If It Ain't Broke, Don't Fix It

    The National Horsemen's Benevolent and Protective Association has adopted a position paper on medication and drug-testing that says any changes in policies in each jurisdiction should be enacted only after there is scientific evidence specific therapeutic drugs shouldn't be used in racehorses.

  • Kafwain, winning the San Vicente earlier this year.

    Kafwain DQ'd from Louisiana Derby; Baffert Wants Uniformity

    The Thoroughbred Corp.'s Kafwain was disqualified from his second-place finish in the March 9 Louisiana Derby at Fair Grounds because he raced with an excessive amount of the bronchodilator clenbuterol. Trainer Bob Baffert did not appeal so Kafwain could make his next racing engagement, but he has called for uniformity in medication rules.

  • Without Definitive Test, Battling EPO Use Big Challenge

    Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.

  • Chairman Hopes Kentucky is Medication Model

    The chairman of the Kentucky Racing Commission said Sept. 13 he hopes a revised race-day medication policy for the Bluegrass state becomes a model for the rest of the country as it pushes toward uniformity in racehorse medication and drug testing.

  • National Medication Policy Again Called a Necessity

    Setting a national policy for racehorse medication is a vital step for the sport's long-term health, a top industry executive told the 2002 Harness Racing Congress in Las Vegas, Nev., Feb. 20.

  • Churchill Downs president Alex Waldrop: "The thing we have to protect above all others is integrity."

    Uniformity a Priority, But How Far Will It Go?

    The racing industry's quest for uniformity in medication and drug testing continued Wednesday with a lively panel discussion on the issue at the University of Arizona Symposium on Racing in Tucson. Meanwhile, the jury is out as to whether there will be considerable change in Kentucky, a major racing state where officials appear split on the issue.